Benzinga's Top #PreMarket Gainers

gained 16.82 percent to $7.50 in pre-market trading. According to a Thursday's press release, Australian Studies confirmed that TRXE-009 kills resistant paediatric brain cancer cells.

shares surged 6.38 percent to $3.50 in pre-market trading. XOMA posted a Q1 net loss of $21.7 million on total revenue of $2.7 million.

shares rose 5.36 percent to $41.50 in pre-market trading after the company reported stronger-than-expected results for the first quarter.

shares gained 4.87 percent to $18.10 in the pre-market trading session after the company reported a $500 million investment from a group of investors.

shares climbed 4.85 percent to $8.00 in pre-market trading. Rocketfuel reported Q1 loss of $0.60 per share on revenue of $104.3 million.